BC-CfE’s Nance Cunningham, Experimental Medicine PhD student, chosen as a UBC Public Scholar

The BC-CfE’s Nance Cunningham, an Experimental Medicine PhD student working in the EMBARC team (Epidemiological, Mathematical and Biostatistical analysis and Research Collaboration in HIV/AIDS) has been chosen as a UBC Public Scholar.The Public Scholars Initiative (PSI)supports creative, action-oriented research designed to address complex challenges and have meaningful public impact as part of a PhD thesis. The award will support Cunningham’s research partnerships with people affected by hepatitis C, and patient advocacy activists.

Read More »

BC-CfE researcher first to identify link between severe intimate partner violence and all-cause mortality among women living with HIV

Globally, one in three women will experience some form of intimate partner violence in their lives. Some North American studies indicate this may be much more likely for women living with HIV. Despite improvements in HIV disease outcomes among women living with HIV in BC, multiple interacting inequities continue to disproportionately impact the health, wellbeing, and survival of women living with HIV.

Read More »

The BC-CfE’s Per-SVR Team Fights for HCV Awareness

Globally, 290 million people are unaware they are living with a hepatitis C virus (HCV) infection. This significant global health problem affects as many as 80,000 individuals here in BC. Today on World Hepatitis Day, the theme is ‘Find the Missing Millions’ in order to raise awareness of the global burden of viral hepatitis and to influence real change.

Read More »

CHIWOS to Launch New Women-Centred HIV Care Toolkits

In order to better support women living with HIV in Canada, the BC-CfE’s Canadian HIV Women’s Sexual & Reproductive Health Cohort Study (CHIWOS) has developed new Women-Centred HIV Care Toolkits. The toolkits were created from an evidence-based, integrated knowledge translation approach.

Read More »
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below